All eyes are on Twitter as both the company itself and legions of salivating marketers try to figure out just what advertising will look like on the hot microblogging site. Of course, advertising is nothing new to Twitter — whether it is legit marketing or sneaky spam ads — but there is no official advertising model just yet. And when there is? What will that mean for pharma marketing? How exactly does one fit fair balance copy within 140 characters? Won’t we just wind up sounding like a bunch of lolcats?

Is this what pharmaceutical ads will look like on Twitter?

New treatment for twitterpations: TWEETMENT™—Clinically proven to cut Twitter notifications by up to 40%. Learn more: http://bit.ly/tweetment

@DDMAC: Sorry that last tweet lacked a fair balance.

New TWEETMENT  for overactive Twitter-use. ISI: AEs incl illtwitteracy, diminishing nest ass, and @AshtonKutcher withdrawal. Pls see full PI.

We may have our work cut out for us.

Ken is a great deal more than just the president of a medical communications company. He is something of a hybrid. He’s part marketing manager, part creative director, and part copywriter. To the chagrin of his peers—but to the delight of his clients—Ken is a consummate perfectionist. As a former creative director for a high-end consumer agency, he challenged his creative teams to go beyond the mundane to produce work with real creative impact, something he’s just as fervent about today. From producing and directing TV commercials, to launching DTC and Rx-to-OTC switches, Ken brings his clients a world of experience in OTC pharmaceuticals as well as business, lifestyle, and high-end consumer products and services. Whether huddled with clients behind a mirror in a market research center in Houston, facilitating a strategic workshop in Madrid, or developing a global campaign either in the New Jersey or California office, Ken is always fully engaged, bringing “bestness” to all areas of his hectic but full life.